Table 3.
Univariate and multivariate analyses of the effect of prognostic factors on the overall survival of patients with resectable small cell lung cancer
Characteristic | Univariate analysis | Multivariate analysis | |||||
---|---|---|---|---|---|---|---|
|
|
||||||
MST (mo) | 3-y OS (%) | χ2 | P | HR | 95% CI | P | |
Sex | 1.260 | 0.262 | |||||
Male | 36 | 49.6 | |||||
Female | NR | 66.3 | |||||
Age | 2.029 | 0.154 | |||||
> 60 | 36 | 73.7 | |||||
≤ 60 | NR | 50.0 | |||||
pT stage | 1.821 | 0.402 | |||||
T1 | NR | 65.5 | |||||
T2 | 38 | 51.7 | |||||
T3 | 19.7 | 50.0 | |||||
pN stage | 7.616 | 0.022 | |||||
N0 | NR | 76.5 | |||||
N1 | 28.9 | 58.1 | |||||
N2 | 22.3 | 28.4 | |||||
Pathologic stage | 1.806 | 0.405 | |||||
I | NR | 72.4 | |||||
II | 24 | 53.9 | |||||
III | 18 | 40.7 | |||||
POCT | 3.922 | 0.048 | 0.322 | 0.121-0.856 | 0.023 | ||
Yes | NR | 61.1 | |||||
No | 17 | 40.0 | |||||
PORT | 2.674 | 0.102 | |||||
Yes | 38 | 51.2 | |||||
No | 22 | 35.7 | |||||
PD-L1 expression | 4.592 | 0.032 | 0.253 | 0.092-0.697 | 0.008 | ||
< 0.05 | 43.2 | 34.0 | |||||
≥ 0.05 | 72.3 | NR |
Abbreviations: MST, median survival time; 3/5-y, 3/5 year; mo, months; NR, not reached; OS, overall survival; POCT, postoperative chemotherapy; PORT, postoperative radiotherapy; PD-L1, programmed cell death ligand 1.